ProCE Banner Activity

Rate of Adverse Events in Clinical Trials of SGLT2 Inhibitors: Meta-analysis of RCTs

Slideset Download
Conference Coverage
In meta-analysis of 62 placebo-controlled RCTs, SGLT2 inhibitors were associated with increased risk of infection and diabetic ketoacidosis but showed similar rates of hypoglycemia, bone fracture, and amputations as placebo.

Released: June 29, 2021

Expiration: June 28, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck